4//SEC Filing
CymaBay Therapeutics, Inc. 4
Accession 0001179110-17-001194
CIK 0001042074operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:33 PM ET
Size
5.4 KB
Accession
0001179110-17-001194
Insider Transaction Report
Form 4
Weiland Robert J.
Director
Transactions
- Award
Stock Option (right to buy)
2017-01-19+12,000→ 12,000 totalExercise: $1.72Exp: 2027-01-18→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option vests in three annual installments from the vesting start date of January 19, 2017.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042074
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:33 PM ET
- Size
- 5.4 KB